J&J to unload Indian consumer brands; Omega taps new U.K. agency; Bayer moves media-buying business;

> Johnson & Johnson ($JNJ) is selling the Indian rights to two consumer brands, Savlon antiseptic soap and Shower to Shower talcum powder, domestic media reports. Report

> Omega Pharma, currently in the process of selling itself, tapped a new agency to handle its U.K. and Ireland accounts; The Corner nabbed the business. Report

> Bayer moved a $11 million media account in Australia from Mediacom to PHD after a global review; worldwide, Mediacom kept four markets and PHD ended up with the other four, including Australia, Mumbrella says. Report

> ViiiV Healthcare expanded its campaign for HIV prevention and treatment in the U.S. South, funding grassroots outreach projects worth more than $2.8 million. Report

> Big Pharma companies are eyeing government contracts in Brazil, wooed by the market share guarantees offered under the new partnerships. Report

And Finally... Sanofi ($SNY) and Regeneron ($REGN) said they started a new study of their experimental drug dupilumab in atopic dermatitis. Release

Suggested Articles

Amgen could soon face new competition in the PCSK9 class, but an efficacy boost in treating high-risk heart attack patients could help keep it ahead.

Having already whiffed on one crucial heart failure trial, Novartis is focusing on "profound" data from its Entresto studies in hopes for another go.

Bristol-Myers Squibb and Pfizer's Eliqus has taken the U.S. warfarin alternative market by storm, but can afib screening amp it up even more?